Hypothesis · not a trading signal
Q4 / FY2026 · Published 2026-07-28 · Source checked 2026-09-06
- 01 / What the issuer reported
- Full-year free cash flow was $3.77bn. Per-share figures reflect the June 2026 ten-for-one stock split.
- 02 / Our hypothesis — not established alpha
- Process control can capture more spend per wafer as defects become more costly; this needs proof beyond AI-related demand.
- 03 / What to measure next
- Process-control intensity versus fab spending, service mix, margin, cash conversion and split-adjusted shares.
- 04 / What would challenge the thesis
- Reassess if inspection intensity or competitive share declines, or cash growth persistently lags reported earnings.
- 05 / Appropriate valuation method
- Mid-cycle DCF/earnings; align both EPS and price to the same split basis.
- 06 / Still missing
- Missing: through-cycle intensity evidence and harmonized share history.
No measured consensus gap or approved price target. A familiar good business can still be an expensive stock.